Abstract:Background and Objective Transplanted stem cells (SCs), owing to their regenerative capacity, represent one of the most promising methods to restore erectile dysfunction (ED). However, insufficient source, invasive procedures, ethical and regulatory issues hamper their use in clinical applications. The endogenous stem/progenitor cells resident in organ and tissues play critical roles for organogenesis during development and for tissue homeostasis in adulthood. Even without any therapeutic intervention, human body has a robust self-healing capability to repair the damaged tissues or organs. Therefore, SCs-for-ED therapy should not be limited to a supply-side approach. The resident endogenous SCs existing in patients could also be a potential target for ED therapy. The aim of this study was to observe the changes of erectile function and histopathological injury of penis in a rat model of bilateral cavernous nerves (CN) injury. To investigate the therapeutic effects of IcarisideII (ICAII) in the neurogenic ED. To explore its underlying mechanisms of ICAII in ameliorating erectile function and pathological changes.

AB047. Activating and Mobilizing Endogenous Stem Cells: a Novel Therapeutic Approach for Erectile Dysfunction